Review
Published on 07 Mar 2022
Pruritus: A Sensory Symptom Generated in Cutaneous Immuno-Neuronal Crosstalk
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.745658
- 4,673 views
- 13 citations
Type at least 3 characters
1,552 articles
Articles
Original Research
Published on 03 Mar 2022
5-HT1F Receptor Agonist Ameliorates Mechanical Allodynia in Neuropathic Pain via Induction of Mitochondrial Biogenesis and Suppression of Neuroinflammation
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.834570
- 3,673 views
- 9 citations
Review
Published on 03 Mar 2022
Inflammation and Cancer: From the Development of Personalized Indicators to Novel Therapeutic Strategies
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.838079
- 7,861 views
- 20 citations
Original Research
Published on 03 Mar 2022
Tofacitinib Decreases Autophagy of Fibroblast-Like Synoviocytes From Rheumatoid Arthritis Patients
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.852802
- 2,679 views
- 10 citations
Review
Published on 02 Mar 2022
The Research Progress of Exosomes in Osteoarthritis, With Particular Emphasis on the Therapeutic Effect
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.731756
- 3,789 views
- 5 citations
Review
Published on 02 Mar 2022
Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators—What is the Evidence so far?
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.838782
- 17,467 views
- 64 citations
Original Research
Published on 01 Mar 2022
Sulforaphane Modulates the Inflammation and Delays Neurodegeneration on a Retinitis Pigmentosa Mice Model
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.811257
- 3,400 views
- 7 citations
Case Report
Published on 28 Feb 2022
Case Report: Tackling Complement Hyperactivation With Eculizumab in Atypical Hemolytic Uremic Syndrome Triggered by COVID-19
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.842473
- 1,706 views
- 6 citations
Original Research
Published on 28 Feb 2022
Direct Thrombin Inhibitor Dabigatran Compromises Pulmonary Endothelial Integrity in a Murine Model of Breast Cancer Metastasis to the Lungs; the Role of Platelets and Inflammation-Associated Haemostasis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.834472
- 2,553 views
- 4 citations
Review
Published on 25 Feb 2022
New Insights of CCR7 Signaling in Dendritic Cell Migration and Inflammatory Diseases
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.841687
- 9,060 views
- 16 citations
Original Research
Published on 24 Feb 2022
Notoginsenoside R1 (NG-R1) Promoted Lymphatic Drainage Function to Ameliorating Rheumatoid Arthritis in TNF-Tg Mice by Suppressing NF-κB Signaling Pathway
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.730579
- 2,513 views
- 8 citations
Original Research
Published on 23 Feb 2022
Pentamidine Alleviates Inflammation and Lipopolysaccharide-Induced Sepsis by Inhibiting TLR4 Activation via Targeting MD2
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.835081
- 3,347 views
- 4 citations
Original Research
Published on 22 Feb 2022
Steroid Treatment in Macular Edema: A Bibliometric Study and Visualization Analysis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.824790
- 5,959 views
- 11 citations
Review
Published on 22 Feb 2022
Autophagy-Inflammation Interplay During Infection: Balancing Pathogen Clearance and Host Inflammation
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.832750
- 4,170 views
- 17 citations
Original Research
Published on 21 Feb 2022
Astragaloside IV Relieves Atherosclerosis and Hepatic Steatosis via MAPK/NF-κB Signaling Pathway in LDLR−/− Mice
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.828161
- 2,794 views
- 11 citations
Review
Published on 18 Feb 2022
Platelets in Non-alcoholic Fatty Liver Disease
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.842636
- 9,861 views
- 5 citations